Inventor · disambiguated record
Paul S. Watson
Also filed as: WATSON PAUL S · WATSON PAUL STEVEN
23 granted patents·8 pending applications·145 citations·filing 1999–2025
94Inventor score
Files withINSPIRE PHARMACEUTICALS INC13SAGE THERAPEUTICS INC9LAMPE JOHN W5BRISTOL MYERS SQUIBB PHARMA CO3SHE JIN1
Top patents by PatentIndex Score
31 records- 0197US11236121B2Crystalline 19-nor C3,3-disubstituted C21-N-pyrazolyl steroidSAGE THERAPEUTICS INC·Filed 2017·Granted Feb 1, 2022·23 cites·5 claims
- 0295US11884696B2Crystalline 19-nor C3,3-disubstituted C21-n-pyrazolyl steroidSAGE THERAPEUTICS INC·Filed 2021·Granted Jan 30, 2024·4 cites·19 claims
- 0393US7335648B2Non-nucleotide composition and method for inhibiting platelet aggregationINSPIRE PHARMACEUTICALS INC·Filed 2005·Granted Feb 26, 2008·15 cites·23 claims
- 0492US8071779B2Cytoskeletal active rho kinase inhibitor compounds, composition and useLAMPE JOHN W·Filed 2007·Granted Dec 6, 2011·36 cites·19 claims
- 0587US7943760B2Non-nucleotide composition for inhibiting platelet aggregationINSPIRE PHARMACEUTICALS INC·Filed 2009·Granted May 17, 2011·4 cites·8 claims
- 0686US7592445B2Non-nucleotide composition and method for inhibiting platelet aggregationINSPIRE PHARMACEUTICALS INC·Filed 2008·Granted Sep 22, 2009·3 cites·12 claims
- 0784US2025304615A1Crystalline 19-nor c3,3-disubstituted c21-n-pyrazolyl steroidSAGE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0883US7320974B2Cytoskeletal active compounds, compositions and useINSPIRE PHARMACEUTICALS INC·Filed 2006·Granted Jan 22, 2008·6 cites·26 claims
- 0982US7414137B2Process for the preparation of 3,4-disubstituted-thiazolidin-2-onesINSPIRE PHARMACEUTICALS INC·Filed 2007·Granted Aug 19, 2008·3 cites·11 claims
- 1082US6441001B12-substituted-4-nitrogen heterocycles as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 1999·Granted Aug 27, 2002·26 cites·59 claims
- 1181US12358942B2Crystalline 19-nor C3,3-disubstituted C21-n-pyrazolyl steroidSAGE THERAPEUTICS INC·Filed 2023·Granted Jul 15, 2025·0 cites·4 claims
- 1278US2023141665A1Neuroactive steroid solutions and their methods of useSAGE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1377US7932376B2Pyrimidine-based non-nucleotide composition and method for inhibiting platelet aggregationINSPIRE PHARMACEUTICALS INC·Filed 2006·Granted Apr 26, 2011·3 cites·22 claims
- 1472US8476295B2Bridged bicyclic RHO kinase inhibitor compounds, composition and useLAMPE JOHN W·Filed 2010·Granted Jul 2, 2013·2 cites·14 claims
- 1571US7504497B2Orally bioavailable compounds and methods for inhibiting platelet aggregationINSPIRE PHARMACEUTICALS INC·Filed 2006·Granted Mar 17, 2009·12 cites·18 claims
- 1668US8604218B2Cytoskeletal active rho kinase inhibitor compounds, composition and useLAMPE JOHN W·Filed 2011·Granted Dec 10, 2013·1 cites·20 claims
- 1768US6706735B22-substituted-4-nitrogen heterocycles as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Mar 16, 2004·3 cites·35 claims
- 1867US6906066B2N-ureidoalkyl-piperidines as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 2003·Granted Jun 14, 2005·3 cites·31 claims
- 1964US7741473B2Process for the preparation of 4,6-disubstituted-tetrahydro-furo, thieno, pyrrolo and cyclopenta-[3,4][1,3]dioxolesINSPIRE PHARMACEUTICALS INC·Filed 2006·Granted Jun 22, 2010·1 cites·19 claims
- 2064US2023057130A1Formulations of 19-nor c3,3-disubstituted c21-n-pyrazolyl steroid and methods of use thereofSAGE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2161US7666861B2Cytoskeletal active compounds, composition and useINSPIRE PHARMACEUTICALS INC·Filed 2007·Granted Feb 23, 2010·0 cites·25 claims
- 2259US2023285417A1Formulations of 19-nor c3,3-disubstituted c21-n-pyrazolyl steroid and methods of use thereofSAGE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2358US7947850B2Process for the preparation of 3,4-disubstituted-thiazolidin-2-onesINSPIRE PHARMACEUTICALS INC·Filed 2008·Granted May 24, 2011·0 cites·11 claims
- 2458US2019350944A1Neuroactive steroid solutions and their methods of useSAGE THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2555US8039465B2Cytoskeletal active compounds, composition and useINSPIRE PHARMACEUTICALS INC·Filed 2010·Granted Oct 18, 2011·0 cites·6 claims
- 2653US8604205B2Cytoskeletal active rho kinase inhibitor compounds, composition and useLAMPE JOHN W·Filed 2012·Granted Dec 10, 2013·0 cites·20 claims
- 2751US8835457B2Bridged bicyclic RHO kinase inhibitor compounds, compositions and useLAMPE JOHN W·Filed 2013·Granted Sep 16, 2014·0 cites·13 claims
- 2850US2019008873A1Neuroactive steroid solutions and their methods of useSAGE THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2943US8158796B2Process for the preparation of Rho-kinase inhibitor compoundsSHE JIN·Filed 2009·Granted Apr 17, 2012·0 cites·13 claims
- 3042US2013131106A1Bifunctional rho kinase inhibitor compounds, composition and useINSPIRE PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 3142US2013131059A1Method for treating ophthalmic diseases using kinase inhibitor compounds in prodrug formsINSPIRE PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Paul S. Watson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →